Based on our vision of “Entry into the world’s top 10 CROs by 2025” and to aid in the processes of creating new global drugs and products through Chemon, we are providing the ultimate in quality research and service on a daily basis to grow Chemon into a company offering a comprehensive range of nonclinical testing services by 2025.